The authors synthesized three derivatives, 46–48, and evaluated their activity against hCAs (Table 11), showing that only compound 47 exhibited a notable selectivity for the cancer-associated CAs IX and XII over cytosolic I and II [35]. The gene discussed is CA9; the disease is cancer.